ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646159 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646159; 2) Community: the network communities that were significantly associated with the response to NSC 646159; 3) Molecule: the relationships between components within communities and NSC 646159; 4) MDR: the compounds that were significantly associated with the NSC 646159.

NSC Compound Enrichment Correlation
NSC 635922 Null 0.000944238008110124 0.58124754
NSC 670789 9-[(Z)-Bromoiodomethylidene]-9,10-dihydrophenanthrene-10-one 0.00103112124545269 0.56522277
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.00103112124545269 0.515505
NSC 255104 Des-O-methylgeldanamycin 0.0010311212454527 0.57860143
NSC 633273 ANTINEOPLASTIC-633273 0.0010311212454527 0.51669331
NSC 619042 Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride 0.00115116014164088 0.66312664
NSC 668844 Null 0.0016365323975257 0.59990583
NSC 146067 cis-Diamminemalonatoplatinum(II) 0.00163653239752571 0.17394413
NSC 271674 Carboxyphthalatoplatinum 0.00163653239752571 0.6961017
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.00163653239752571 0.62315815
Total:86  Current:4    [First] [Prev] [Next] [Last]